The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry Trial N/A Active, not recruiting Jan. 15, 2025
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis Trial Phase 4 Completed Jan. 13, 2025
Comparative Effects of Alexander Techniques and Feldenkrais Method in Parkinson's Disease Trial N/A Enrolling by invitation Jan. 13, 2025
Development of a Multifunctional Rehabilitation Device for Persons With Parkinson's Disease Trial N/A Completed Jan. 13, 2025
Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients Trial N/A Recruiting Jan. 13, 2025
Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE) Trial N/A Enrolling by invitation Jan. 13, 2025
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease Trial N/A Recruiting Jan. 12, 2025
Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System Trial N/A Enrolling by invitation Jan. 7, 2025
Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease Trial N/A Not yet recruiting Jan. 6, 2025
A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease Trial Phase 2 Withdrawn Jan. 6, 2025
Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease Trial Phase 2 Withdrawn Jan. 6, 2025
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease Trial Phase 2 Completed Dec. 31, 2024
Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. Trial N/A Not yet recruiting Dec. 31, 2024
Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease Trial N/A Completed Dec. 26, 2024
Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation Trial N/A Completed Dec. 26, 2024